SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $44,898,000 | +54.0% | 264,231 | +4.5% | 0.06% | +30.6% |
| Q1 2020 | $29,156,000 | +7.0% | 252,768 | +5.9% | 0.05% | +22.5% |
| Q4 2019 | $27,253,000 | +71.2% | 238,588 | +27.9% | 0.04% | +66.7% |
| Q3 2019 | $15,923,000 | +36.9% | 186,491 | +11.0% | 0.02% | +41.2% |
| Q2 2019 | $11,633,000 | +3.3% | 168,080 | +9.3% | 0.02% | 0.0% |
| Q1 2019 | $11,261,000 | +33.7% | 153,749 | +3.4% | 0.02% | +13.3% |
| Q4 2018 | $8,425,000 | -43.0% | 148,691 | -22.4% | 0.02% | -31.8% |
| Q3 2018 | $14,785,000 | +22.4% | 191,715 | +5.4% | 0.02% | +22.2% |
| Q2 2018 | $12,075,000 | +49.8% | 181,879 | +18.1% | 0.02% | +50.0% |
| Q1 2018 | $8,061,000 | +18.4% | 154,016 | +21.1% | 0.01% | +20.0% |
| Q4 2017 | $6,807,000 | +293.9% | 127,230 | +300.7% | 0.01% | +233.3% |
| Q3 2017 | $1,728,000 | -8.4% | 31,753 | -12.9% | 0.00% | 0.0% |
| Q2 2017 | $1,887,000 | -24.4% | 36,471 | -8.2% | 0.00% | -25.0% |
| Q1 2017 | $2,496,000 | +46.8% | 39,711 | +23.3% | 0.00% | +33.3% |
| Q4 2016 | $1,700,000 | -31.1% | 32,211 | -29.5% | 0.00% | -25.0% |
| Q3 2016 | $2,468,000 | +725.4% | 45,700 | +517.6% | 0.00% | +300.0% |
| Q2 2016 | $299,000 | +15.0% | 7,400 | 0.0% | 0.00% | – |
| Q1 2016 | $260,000 | -21.7% | 7,400 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $332,000 | +16.5% | 7,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $285,000 | -20.4% | 7,400 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $358,000 | +22.2% | 7,400 | -10.8% | 0.00% | 0.0% |
| Q1 2015 | $293,000 | +12.7% | 8,300 | +2.5% | 0.00% | – |
| Q4 2014 | $260,000 | -64.7% | 8,100 | -59.1% | 0.00% | -100.0% |
| Q3 2014 | $736,000 | -12.2% | 19,800 | -9.6% | 0.00% | 0.0% |
| Q2 2014 | $838,000 | -44.1% | 21,900 | -33.4% | 0.00% | -66.7% |
| Q1 2014 | $1,499,000 | +73.9% | 32,900 | +52.3% | 0.00% | +50.0% |
| Q4 2013 | $862,000 | -27.7% | 21,600 | -20.6% | 0.00% | 0.0% |
| Q3 2013 | $1,192,000 | +48.6% | 27,200 | +6.7% | 0.00% | 0.0% |
| Q2 2013 | $802,000 | – | 25,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
| Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
| Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
| Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
| NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
| Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
| WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
| Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
| CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
| Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |